Acute ST-segment elevation myocardial infarction and prior stroke: An analysis from the Magnesium in Coronaries (MAGIC) trial

American Heart Journal

Volumn 148, Issue 6, 2004, Pages 1012-1019

  Cooper, Howard A ^a   Domanski, Michael J ^b   Rosenberg, Yves ^b   Norman, James ^b   Scott, Judith H ^c   Assmann, Susan F ^c   McKinlay, Sonja M ^c   Hochman, Judith S ^d   Antman, Elliott M ^e  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; BLOOD CLOT LYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; RISK FACTOR; ST SEGMENT ELEVATION; STROKE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LOGISTIC MODELS; MAGNESIUM SULFATE; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RECURRENCE; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 10644221872     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.02.017     Document Type: Article

References (16)

1. Hillis L.D., Forman S., Braunwald E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. J Am Coll Cardiol. 16:1990;313-315
2. Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation. 91:1995;1659-1668
3. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction a convenient, bedside, clinical score for risk assessment at presentation. An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial substudy. Circulation. 102:2000;2031-2037
4. Tanne D., Gottlieb S., Caspi A., et al. Treatment and outcome of patients with acute myocardial infarction and prior cerebrovascular events in the thrombolytic era the Israeli Thrombolytic National Survey. Arch Intern Med. 158:1998;601-606
5. Pfeffer M.A., Moye L.A., Braunwald E., et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. JAMA. 266:1991;528-532
6. Ketley D., Woods K.L. Selection factors for the use of thrombolytic treatment in acute myocardial infarction a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group. Br Heart J. 74:1995;224-228
7. Cupples L.A., Gagnon D.R., Wong N.D., et al. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction. The Framingham Study. Am Heart J. 125:1993;863-872
8. Cragg D.R., Friedman H.Z., Bonema J.D., et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med. 115:1991;173-177
9. The MAGIC Steering Committee. Rationale and design of the Magnesium in Coronaries (MAGIC) study a clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction. Am Heart J. 139:2000;10-14
10. The Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002;360:1189-96
11. Gore J.M., Granger C.B., Simoons M.L., et al. Stroke after thrombolysis mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation. 92:1995;2811-2818
12. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 34:1999;890-911
13. Love B.B., Grover-McKay M., Biller J., et al. Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease. Stroke. 23:1992;939-945
14. Reicher-Reiss H., Jonas M., Tanne D., et al. Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol. 82:1998;1532-1535. A7
15. Komrad M.S., Coffey C.E., Coffey K.S., et al. Myocardial infarction and stroke. Neurology. 34:1984;1403-1409
16. Cotter G., Cannon C.P., McCabe C.H., et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. Am Heart J. 145:2003;622-627